# MOTPOLY XR
> **NDA216185** · New Drug Application · Sponsor: AUCTA · Approved 2023-05-04
## Drug
- **FDA Application Number:** NDA216185
- **Application type:** New Drug Application
- **Brand name:** MOTPOLY XR
- **Generic name:** LACOSAMIDE
- **Active ingredients:** LACOSAMIDE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AUCTA
- **Manufacturer:** Aucta Pharmaceuticals, Inc.
- **First approval:** 2023-05-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216185)
---
*MORVS · CC0 1.0*